|Last Price$58.34||Day Change (%)1.02%|
|Open Price$58.28||Day Change ($)0.59|
|Day Range58.15–58.54||52-Week Range52.49–63.62|
As of Mon 3/30/2015 6:04:00 PM | USD
FDA delays meeting on Merck's surgery drug
FDA Cancels Advisory Panel's Meeting on Merck Surgery Drug -- Update
FDA Cancels Panel Meeting on Merck Surgery Drug
FDA Cancels Advisory Panel's Meeting on Merck Surgery Drug
Merus Labs Appoints New Director and Provides European Update
U.S. Vaccines Market to Be Driven by High Demand for Pediatric Vaccines, to Reach US$17.4 Billion by 2018: Transparency Market Research
The sale to Bayer monetizes Merck's consumer unit at a strong valuation, and removes Merck from an area where it lacks scale.
Australia stocks follow Wall Street down sharply; banks weak
American's managers have been busy buying unloved large caps.